Malignant ovarian tumors in children: 22 years of experience at a single institution

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 5, 2000, Pages 422-427

  Akyüz, Canan ^a   Varan, Ali ^a   Büyükpamukçu, Nebil ^a   Kutluk, Tezer ^a   Büyükpamukçu, Münevver ^b  

^a Institute of Oncology   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Ovarian tumors; Prognostic factors; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BEP PROTOCOL; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MORTALITY; NEWBORN; OVARY TUMOR; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0034266433     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200009000-00007     Document Type: Article

References (21)

1. Raney Jr RB Sinclair L, Uri A, Schnaufer L, Cooper A, Littman P. Malignant ovarian tumors in children and adolescents. Cancer 1987; 59: 1214-20.
2. Castleberry RP, Cushing B, Perlman E, Hawkins EP. Germ cell tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven, 1997: 921-45.
3. Ablin AR, Krailo MD, Ramsay NKC, et al. Results of treatment of malignant germ cell tumors in 93 children: A report from the Childrens Cancer Study Group. J Clin Oncol 1991; 9: 1782-92.
4. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR. Results of the United Kingdom Children’s Cancer Study Group’s malignant germ cell tumor studies. Cancer 1989; 63: 1657-67.
5. Marina N, Fontanesi J, Kun L, et al. Treatment of childhood germ cell tumors: Review of the S. Jude Experience from 1979-1988. Cancer 1992; 70: 2568-75.
6. Wollner N, Ghavimi F, Wachtel A, Luks E, Exelby P, Woodruff J. Germ cell tumors in children: Gonadal and extragonadal. Med Pediatr Oncol 1991; 19: 228-39.
7. Hawkins EP, Finegold MJ, Hawkins HK, Krischer JP, Starling KA, Weinberg A. Nongerminomatous malignant germ cell tumors in children: A review of 89 cases from the Pediatric Oncology Group, 1971-1984. Cancer 1986; 58: 2579-84.
8. Brodeur GM, Howarth CB, Pratt CB, Caces J, Omar Hustu H. Malignant germ cell tumors in 57 children and adolescents. Cancer 1981; 48: 1890-8.
9. Cangir A, Smith J, van Eys J. Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapy. Cancer 1978; 42: 1234-8.
10. Kottmeier HL. Classification and staging of malignant tumors of the female pelvis. Int J Gynaecol Obstet 1971; 9: 172-80.
11. Dehner LP. Gonadal and extragonadal germ cell neoplasia of childhood. Hum Pathol 1983; 14: 493-511.
12. Pinkerton CR, Broadbent V, Horwich A, et al. JEB: A carboplatin based regimen for malignant germ cell tumours in children. Br J Cancer 1990; 62: 257-62.
13. Baranzelli MC, Flamant F, De Lumley L, Le Gall E, Lejars O. Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the " Société Française d’Oncologie Pédiatrique” MGCT 1985-1989 study. Med Pediatr Oncol 1993; 21: 395-401.
14. Gershenson DM. Update on malignant ovarian germ cell tumors. Cancer 1993; 71: 1581-90.
15. Wollner N, Exelby PR, Woodruff JM, Cham WC, Lois Murphy M, Lewis JL. Malignant ovarian tumors in childhood: prognosis in relation to initial therapy. Cancer 1976; 37: 1953-64.
16. Kapoor G, Advani SH, Nair CN, et al. Pediatric germ cell tumor: an experience with BEP. J Pediatr Hematol Oncol 1995; 17: 318-24.
17. Ghosn M, Droz JP, Theodore C, et al. Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin: a VlhP regimen. Cancer 1988; 62: 24-7.
18. Nichols CR, Andersen J, Lazarus HM, et al. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 1992; 10: 558-63.
19. Devalck C, Tempels D, Ferster A, et al. Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues. Med Pediatr Oncol 1994; 22: 208-10.
20. Eisenhauer EA, ten Bokkel Huinink WW, Swenerton KD, et al. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 1994; 12: 2654-66.
21. Hoskins P, Eisenhauer E, Beare S, et al. Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada clinical trials group study. J Clin Oncol 1998; 16: 2233-7.